Applied Therapeutics (APLT) News Today → “The Stock Market’s Bull Run is Far from Over” -Barrons (From Vertical Research Advisory) (Ad) Free APLT Stock Alerts $6.80 -0.05 (-0.73%) (As of 03/28/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineApplied Therapeutics Says FDA Extends Review Period Of NDA For Govorestatmarkets.businessinsider.com - March 29 at 3:31 AMUPDATE 1-US FDA extends review of Applied Therapeutics' genetic disease drugfinance.yahoo.com - March 28 at 10:30 PMUS FDA extends review of Applied Therapeutics' genetic disease drugreuters.com - March 28 at 4:52 PMApplied Therapeutics Provides FDA Update on PDUFA Target Action Date for Govorestat for the Treatment of Classic Galactosemiaglobenewswire.com - March 28 at 4:30 PMApplied Therapeutics (NASDAQ:APLT) Receives New Coverage from Analysts at Royal Bank of Canadaamericanbankingnews.com - March 27 at 2:56 AMApplied Therapeutics (NASDAQ:APLT) Now Covered by Royal Bank of Canadamarketbeat.com - March 26 at 8:48 AMApplied Therapeutics (NASDAQ:APLT) Shares Gap Down to $6.75marketbeat.com - March 25 at 1:33 PMApplied Therapeutics (NASDAQ:APLT) Shares Up 4.6%marketbeat.com - March 20 at 4:30 PMApplied therapeutics CCO sells shares worth over $263kinvesting.com - March 20 at 6:44 AMApplied therapeutics CFO sells shares worth over $150kinvesting.com - March 20 at 6:44 AMApplied Therapeutics (NASDAQ:APLT) Shares Gap Down After Insider Sellingamericanbankingnews.com - March 20 at 1:52 AMApplied Therapeutics (NASDAQ:APLT) Shares Gap Down Following Insider Sellingmarketbeat.com - March 19 at 10:33 AMApplied Therapeutics, Inc. (NASDAQ:APLT) Insider Riccardo Perfetti Sells 110,804 Shares of Stockamericanbankingnews.com - March 19 at 5:58 AMApplied Therapeutics, Inc. (NASDAQ:APLT) CFO Leslie D. Funtleyder Sells 28,727 Shares of Stockamericanbankingnews.com - March 19 at 5:18 AMInsider Selling: Applied Therapeutics, Inc. (NASDAQ:APLT) CFO Sells 28,727 Shares of Stockinsidertrades.com - March 19 at 5:17 AMApplied Therapeutics, Inc. (NASDAQ:APLT) CEO Shoshana Shendelman Sells 318,573 Sharesinsidertrades.com - March 19 at 4:44 AMUBS Group Increases Applied Therapeutics (NASDAQ:APLT) Price Target to $13.00americanbankingnews.com - March 19 at 3:38 AMLeslie D. Funtleyder Sells 28,727 Shares of Applied Therapeutics, Inc. (NASDAQ:APLT) Stockmarketbeat.com - March 18 at 8:17 PMApplied Therapeutics (NASDAQ:APLT) Price Target Increased to $13.00 by Analysts at UBS Groupmarketbeat.com - March 18 at 3:11 PMLeerink Partnrs Research Analysts Increase Earnings Estimates for Applied Therapeutics, Inc. (NASDAQ:APLT)marketbeat.com - March 11 at 2:18 AMSchonfeld Strategic Advisors LLC Makes New $1.14 Million Investment in Applied Therapeutics, Inc. (NASDAQ:APLT)marketbeat.com - March 10 at 5:45 AMApplied Therapeutics (NASDAQ:APLT) Trading 6.5% Higher marketbeat.com - March 8 at 3:21 PMApplied Therapeutics Inc (APLT) Announces Year-End 2023 Financial Results and Clinical Progressfinance.yahoo.com - March 8 at 7:42 AMUBS Group Increases Applied Therapeutics (NASDAQ:APLT) Price Target to $12.00marketbeat.com - March 6 at 1:49 PMWorth Venture Partners LLC Makes New $483,000 Investment in Applied Therapeutics, Inc. (NASDAQ:APLT)marketbeat.com - March 6 at 12:58 PMApplied Therapeutics Reports Fourth Quarter and Year-end 2023 Financial Resultsglobenewswire.com - March 6 at 7:00 AMApplied Therapeutics (NASDAQ:APLT) Trading Down 5.7%marketbeat.com - March 5 at 2:52 PMArmistice Capital LLC Takes Position in Applied Therapeutics, Inc. (NASDAQ:APLT)marketbeat.com - March 3 at 10:50 AMBuy Rating Affirmed for Applied Therapeutics as FDA Prioritizes Govorestat, Signaling Strong Market Prospectsmarkets.businessinsider.com - March 1 at 8:20 AMOptimistic Buy Rating for Applied Therapeutics Amid Favorable Drug Approval Prospects and Strong Financial Positionmarkets.businessinsider.com - March 1 at 8:20 AMApplied Therapeutics Shares Surge on FDA Review, $100 Million Funding Roundmarketwatch.com - February 28 at 5:46 PMApplied Therapeutics Rallies After Announcing Private Placement Of Sharesmarkets.businessinsider.com - February 28 at 12:45 PMFDA Grants Review Date For Applied Therapeutics' First Commercial Product For Rare Metabolic Disordermsn.com - February 28 at 12:45 PMApplied Therapeutics (NASDAQ:APLT) Reaches New 1-Year High at $9.39marketbeat.com - February 28 at 11:29 AMWhy Is Applied Therapeutics (APLT) Stock Up 59% Today?investorplace.com - February 28 at 9:48 AMApplied Therapeutics Announces $100 Million Private Placementglobenewswire.com - February 28 at 8:05 AMApplied Therapeutics Announces FDA Acceptance and Priority Review of New Drug Application for Govorestat for the Treatment of Classic Galactosemiaglobenewswire.com - February 28 at 8:00 AMApplied Therapeutics (APLT) Price Target Increased by 20.65% to 9.44msn.com - February 24 at 10:35 PMEAM Investors LLC Invests $975,000 in Applied Therapeutics, Inc. (NASDAQ:APLT)marketbeat.com - February 23 at 8:47 AMLatest News for Applied Therapeutics Stock (NASDAQ:APLT)benzinga.com - February 23 at 12:49 AMLeerink Partners Initiates Coverage of Applied Therapeutics (APLT) with Outperform Recommendationmsn.com - February 22 at 7:48 PMApplied Therapeutics Stock (NASDAQ:APLT), Analyst Ratings, Price Targets, Predictionsbenzinga.com - February 22 at 9:48 AMApplied Therapeutics (NASDAQ:APLT) Research Coverage Started at SVB Leerinkmarketbeat.com - February 22 at 7:20 AMAPLT Mar 2024 5.000 putfinance.yahoo.com - February 18 at 11:43 PMAPLT Mar 2024 2.500 putfinance.yahoo.com - February 18 at 8:41 AMApplied Therapeutics: Speedy Regulatory Review Of Govorestat Might Be Possibleseekingalpha.com - February 16 at 5:49 PMApplied Therapeutics (NASDAQ:APLT) PT Raised to $7.00marketbeat.com - February 16 at 12:38 PMAIGH Capital Management LLC Makes New $1.98 Million Investment in Applied Therapeutics, Inc. (NASDAQ:APLT)marketbeat.com - February 16 at 12:22 PMWhy Is Rare Disease-Focused Applied Therapeutics Stock Trading Higher Today?msn.com - February 15 at 9:45 PMApplied Therapeutics Stock Gains Over Positive Results From Interim Analysis Of Govorestatmarkets.businessinsider.com - February 15 at 11:43 AM Get Applied Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for APLT and its competitors with MarketBeat's FREE daily newsletter. Email Address “The Stock Market’s Bull Run is Far from Over” -Barrons (Ad)Barron's reports that the "stock market's bull run is FAR from over…" And recent economic growth will fuel the price of select stocks in the coming months! Click here for all the details now… APLT Media Mentions By Week APLT Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. APLT News Sentiment▼0.570.61▲Average Medical News Sentiment APLT News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. APLT Articles This Week▼92▲APLT Articles Average Week Get Applied Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for APLT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: OPKO Health News Aerovate Therapeutics News Aurinia Pharmaceuticals News Wave Life Sciences News Longboard Pharmaceuticals News Y-mAbs Therapeutics News Enliven Therapeutics News Pharming Group News Savara News Bicycle Therapeutics News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:APLT) was last updated on 3/29/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders Alliance“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryAI Cracks Open Largest Untapped Energy Reserve on EarthBanyan Hill PublishingThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyOnly a fool would buy Nvidia today… Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Applied Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.